ALVARO ORJUELA to Humans
This is a "connection" page, showing publications ALVARO ORJUELA has written about Humans.
Connection Strength
0.057
-
The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant. Am J Kidney Dis. 2015 Dec; 66(6):1105-6.
Score: 0.013
-
High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus. Am J Nephrol. 2015; 41(3):241-7.
Score: 0.012
-
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):504-512.
Score: 0.006
-
Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. Pediatr Nephrol. 2024 Oct; 39(10):2959-2968.
Score: 0.006
-
International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24?months. Pediatr Nephrol. 2023 11; 38(11):3699-3709.
Score: 0.005
-
How common is chronic kidney disease in children with lupus nephritis? Pediatr Nephrol. 2023 06; 38(6):1701-1705.
Score: 0.005
-
Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford). 2022 05 30; 61(6):2563-2571.
Score: 0.005
-
Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1859-1865.
Score: 0.004